These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35522054)

  • 1. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers.
    Becker S; Fassio F; Muñoz-Cano R; Klimek L; Vidal C; Heath MD; Kündig TM; Vogelberg C; Toran C; Jensen-Jarolim E; Heffler E; Tomazic PV; Feindor M; Hewings S; Carreno T; Morales M; Mösges R; Skinner MA; Graessel A; Hernandez D; Kramer MF
    J Investig Allergol Clin Immunol; 2022 Oct; 32(5):345-356. PubMed ID: 35522054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific Immunotherapy for Inhalant Allergens in Children.
    Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G
    Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of adjuvants in allergen-immunotherapy.
    Klimek L; Schmidt-Weber CB; Kramer MF; Skinner MA; Heath MD
    Expert Rev Clin Immunol; 2017 Jun; 13(6):599-610. PubMed ID: 28162007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
    Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
    Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
    Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Overview of Allergen-specific Immunotherapy Types, Recombinant and Natural Extract Allergens in the Diagnosis and Treatment of Allergies.
    Asoudeh Moghanloo S; Forouzanfar M; Jafarinia M; Fazlollahi MR; Kardar GA
    Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):494-511. PubMed ID: 36341559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.
    Englert L; Mahler V; Bonertz A
    Curr Allergy Asthma Rep; 2021 May; 21(5):32. PubMed ID: 33970347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding differences in allergen immunotherapy products and practices in North America and Europe.
    Mahler V; Esch RE; Kleine-Tebbe J; Lavery WJ; Plunkett G; Vieths S; Bernstein DI
    J Allergy Clin Immunol; 2019 Mar; 143(3):813-828. PubMed ID: 30850069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel adjuvants in allergen-specific immunotherapy: where do we stand?
    Lin YJ; Zimmermann J; Schülke S
    Front Immunol; 2024; 15():1348305. PubMed ID: 38464539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants.
    Sadeghi M; Asadirad A; Koushki K; Keshavarz Shahbaz S; Dehnavi S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109327. PubMed ID: 36257257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs.
    Mueller RS; Jensen-Jarolim E; Roth-Walter F; Marti E; Janda J; Seida AA; DeBoer D
    Allergy; 2018 Oct; 73(10):1989-1999. PubMed ID: 29675865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen extracts for immunotherapy: to mix or not to mix?
    Nony E; Martelet A; Jain K; Moingeon P
    Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality requirements for allergen extracts and allergoids for allergen immunotherapy.
    Zimmer J; Bonertz A; Vieths S
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():4-11. PubMed ID: 29128092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
    Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
    World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future.
    Hesse L; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Pharmacol Ther; 2022 Sep; 237():108115. PubMed ID: 35063570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy.
    Nelson HS
    Allergy Asthma Proc; 2020 Jan; 41(1):26-37. PubMed ID: 31888780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.